27 research outputs found
Polimorfismo de deleção de 19 pares de bases do gene dihidrofolato redutase (DHFR): risco materno para síndrome de Down e metabolismo do folato
CONTEXT AND OBJECTIVE: Polymorphisms in genes involved in folate metabolism may modulate the maternal risk of Down syndrome (DS). This study evaluated the influence of a 19-base pair (bp) deletion polymorphism in intron-1 of the dihydrofolate reductase (DHFR) gene on the maternal risk of DS, and investigated the association between this polymorphism and variations in the concentrations of serum folate and plasma homocysteine (Hcy) and plasma methylmalonic acid (MMA). DESIGN AND SETTING: Analytical cross-sectional study carried out at Faculdade de Medicina de São José do Rio Preto (Famerp). METHODS: 105 mothers of individuals with free trisomy of chromosome 21, and 184 control mothers were evaluated. Molecular analysis on the polymorphism was performed using the polymerase chain reaction (PCR) through differences in the sizes of fragments. Folate was quantified by means of chemiluminescence, and Hcy and MMA by means of liquid chromatography and sequential mass spectrometry. RESULTS: There was no difference between the groups in relation to allele and genotype frequencies (P = 0.44; P = 0.69, respectively). The folate, Hcy and MMA concentrations did not differ significantly between the groups, in relation to genotypes (P > 0.05). CONCLUSIONS: The 19-bp deletion polymorphism of DHFR gene was not a maternal risk factor for DS and was not related to variations in the concentrations of serum folate and plasma Hcy and MMA in the study population.CONTEXTO E OBJETIVO: Polimorfismos em genes do metabolismo do folato podem modular o risco materno para síndrome de Down (SD). Este estudo avaliou a influência do polimorfismo de deleção de 19 pares de base (pb) no íntron 1 do gene dihidrofolato redutase (DHFR) no risco materno para SD e investigou a associação entre esse polimorfismo e variações nas concentrações de folato sérico, homocisteína (Hcy) e ácido metilmalônico (MMA) plasmáticos. TIPO DE ESTUDO E LOCAL: Estudo transversal analítico realizado na Faculdade de Medicina de São José do Rio Preto (Famerp). MÉTODOS: 105 mães de indivíduos com trissomia livre do cromossomo 21 e 184 mães controles foram avaliadas. A análise molecular do polimorfismo foi realizada pela reação em cadeia da polimerase (PCR) por diferença de tamanho dos fragmentos. O folato foi quantificado por quimioluminescência, e Hcy e MMA foram determinados por cromatografia líquida/espectrometria de massas sequencial. RESULTADOS: Não houve diferença entre os grupos em relação às frequências alélica e genotípica (P = 0,44; P = 0,69, respectivamente). As concentrações de folato, Hcy e MMA não mostraram diferença significativa entre os genótipos, entre grupos (P > 0,05). CONCLUSÕES: O polimorfismo de deleção de 19 pb do gene DHFR não é um fator de risco materno para SD e não está relacionado com variações nas concentrações de folato sérico, Hcy e MMA plasmáticos na população estudada.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Faculdade de Medicina de São José do Rio Pret
Polimorfismo de deleção de 19 pares de bases do gene dihidrofolato redutase (DHFR): risco materno para síndrome de Down e metabolismo do folato
Polymorphisms in genes involved in folate metabolism may modulate the maternal risk of Down syndrome (DS). This study evaluated the influence of a 19-base pair (bp) deletion polymorphism in intron-1 of the dihydrofolate reductase (DHFR) gene on the maternal risk of DS, and investigated the association between this polymorphism and variations in the concentrations of serum folate and plasma homocysteine (Hcy) and plasma methylmalonic acid (MMA). DESIGN AND SETTING: Analytical cross-sectional study carried out at Faculdade de Medicina de São José do Rio Preto (Famerp). METHODS: 105 mothers of individuals with free trisomy of chromosome 21, and 184 control mothers were evaluated. Molecular analysis on the polymorphism was performed using the polymerase chain reaction (PCR) through differences in the sizes of fragments. Folate was quantified by means of chemiluminescence, and Hcy and MMA by means of liquid chromatography and sequential mass spectrometry. RESULTS: There was no difference between the groups in relation to allele and genotype frequencies (P = 0.44; P = 0.69, respectively). The folate, Hcy and MMA concentrations did not differ significantly between the groups, in relation to genotypes (P > 0.05). CONCLUSIONS: The 19-bp deletion polymorphism of DHFR gene was not a maternal risk factor for DS and was not related to variations in the concentrations of serum folate and plasma Hcy and MMA in the study population1284215218CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQFUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO - FAPESP302157/2008-52008/04649-3Polimorfismos em genes do metabolismo do folato podem modular o risco materno para síndrome de Down (SD). Este estudo avaliou a influência do polimorfismo de deleção de 19 pares de base (pb) no íntron 1 do gene dihidrofolato redutase (DHFR) no risco materno para SD e investigou a associação entre esse polimorfismo e variações nas concentrações de folato sérico, homocisteína (Hcy) e ácido metilmalônico (MMA) plasmáticos. TIPO DE ESTUDO E LOCAL: Estudo transversal analítico realizado na Faculdade de Medicina de São José do Rio Preto (Famerp). MÉTODOS: 105 mães de indivíduos com trissomia livre do cromossomo 21 e 184 mães controles foram avaliadas. A análise molecular do polimorfismo foi realizada pela reação em cadeia da polimerase (PCR) por diferença de tamanho dos fragmentos. O folato foi quantificado por quimioluminescência, e Hcy e MMA foram determinados por cromatografia líquida/espectrometria de massas sequencial. RESULTADOS: Não houve diferença entre os grupos em relação às frequências alélica e genotípica (P = 0,44; P = 0,69, respectivamente). As concentrações de folato, Hcy e MMA não mostraram diferença significativa entre os genótipos, entre grupos (P > 0,05). CONCLUSÕES: O polimorfismo de deleção de 19 pb do gene DHFR não é um fator de risco materno para SD e não está relacionado com variações nas concentrações de folato sérico, Hcy e MMA plasmáticos na população estudad
Genetic polymorphisms modulate the folate metabolism of Brazilian individuals with Down syndrome
Individuals with Down syndrome (DS) carry three copies of the Cystathionine beta-synthase (C beta S) gene. The increase in the dosage of this gene results in an altered profile of metabolites involved in the folate pathway, including reduced homocysteine (Hcy), methionine, S-adenosylhomocysteine (SAH) and S-adenosylmethionine (SAM). Furthermore, previous studies in individuals with DS have shown that genetic variants in genes involved in the folate pathway influence the concentrations of this metabolism's products. The purpose of this study is to investigate whether polymorphisms in genes involved in folate metabolism affect the plasma concentrations of Hcy and methylmalonic acid (MMA) along with the concentration of serum folate in individuals with DS. Twelve genetic polymorphisms were investigated in 90 individuals with DS (median age 1.29 years, range 0.07-30.35 years; 49 male and 41 female). Genotyping for the polymorphisms was performed either by polymerase chain reaction (PCR) based techniques or by direct sequencing. Plasma concentrations of Hcy and MMA were measured by liquid chromatography-tandem mass spectrometry as previously described, and serum folate was quantified using a competitive immunoassay. Our results indicate that the MTHFR C677T, MTR A2756G, TC2 C776G and BHMT G742A polymorphisms along with MMA concentration are predictors of Hcy concentration. They also show that age and Hcy concentration are predictors of MMA concentration. These findings could help to understand how genetic variation impacts folate metabolism and what metabolic consequences these variants have in individuals with trisomy 21.Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/15944-5, 03/09931-5]Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302157/2008-5]Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [CGPP 046/2006
Improved serological detection of rheumatoid arthritis: a highly antigenic mimotope of carbonic anhydrase III selected in a murine model by phage display
© 2015 Araujo et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Introduction: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that affects around 1% of the human population worldwide. RA diagnosis can be difficult as there is no definitive test for its detection. Therefore, the aim of this study was to identify biomarkers that could be used for RA diagnosis.
Methods: Sera from a collagen-induced arthritis mouse model were used to select potential biomarkers for RA diagnosis by phage display technology. In silico and in vitro analyses were performed to characterize and validate the selected peptides. Samples were classified into three groups: RA; two other immune-mediated rheumatic diseases (systemic lupus erythematosus (SLE) and ankylosing spondylitis (AS)); and healthy controls (HC). Enzyme-linked immunosorbent assay (ELISA) was carried out to determine antibody levels, and diagnostic parameters were determined by constructing receiver operating characteristic curves. Mass spectrometry and Western blot were performed to identify the putative autoantigen that was mimicked by a highly reactive mimotope.
Results: After three rounds of selection, 14 clones were obtained and tested for immunoreactivity analysis against sera from RA and HC groups. The phage-fused peptide with the highest immunoreactivity (M12) was synthesized, and was able to efficiently discriminate RA patients from SLE, AS and HCs (p < 0.0001) by ELISA. The specificity and sensitivity of anti-M12 antibodies for RA diagnosis were 91 % and 84.3 %, respectively. The M12 peptide was identified as one that mimics a predicted antigenic site of the carbonic anhydrase III (CAIII) protein, a ubiquitous biomarker that has been identified in patients with other diseases.
Conclusion: M12 is the first peptide associated with the CAIII protein that may be used as an antigen for antibody detection to aid in RA diagnosis with high sensitivity and specificity.This study was supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Foundation, Ministry of Education of Brazil (CSF SDW-2027/13-5) and the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).info:eu-repo/semantics/publishedVersio
Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry
Abstract\ud
\ud
Background\ud
Chronic hepatitis B (CHB) virus infection is a major cause of hepatocellular carcinoma (HCC), as late diagnosis is the main factor for the poor survival of patients. There is an urgent need for accurate biomarkers for early diagnosis of HCC. The aim of the study was to explore the serum lipidome profiles of hepatitis B-related HCC to identify potential diagnostic biomarkers.\ud
\ud
\ud
Methods\ud
An ultraperformance liquid chromatography mass spectrometry (UPLC-MS) lipidomic method was used to characterize serum profiles from HCC (n = 32), liver cirrhosis (LC) (n = 30), CHB (n = 25), and healthy subjects (n = 34). Patients were diagnosed by clinical laboratory and imaging evidence and all presented with CHB while healthy controls had normal liver function and no infectious diseases.\ud
\ud
\ud
Results\ud
The UPLC-MS-based serum lipidomic profile provided more accurate diagnosis for LC patients than conventional alpha-fetoprotein (AFP) detection. HCC patients were discriminated from LC with 78 % sensitivity and 64 % specificity. In comparison, AFP showed sensitivity and specificity of 38 % and 93 %, respectively. HCC was differentiated from CHB with 100 % sensitivity and specificity using the UPLC-MS approach. Identified lipids comprised glycerophosphocolines, glycerophosphoserines and glycerophosphoinositols.\ud
\ud
\ud
Conclusions\ud
UPLC-MS lipid profiling proved to be an efficient and convenient tool for diagnosis and screening of HCC in a high-risk population.The Fleury SA Group supported this work and AMPC received a doctorate\ud
scholarship from Fundação de Amparo à Pesquisa do Estado de São Paulo –\ud
FAPESP (no. 2013/03701-0). The funding agencies did not interfere in the\ud
scientific aspects of the study
19-base pair deletion polymorphism of the dihydrofolate reductase (DHFR) gene: maternal risk of Down syndrome and folate metabolism
DNA adducts from lipoperoxidation products: characterization, detection, incorporation into oligonucleotides and biological implications
Compostos carcinogênicos estruturalmente diversos ligam-se covalentemente ao DNA formando adutos que, se não reparados, provocam mutações. Inicialmente relacionados apenas a compostos exógenos, atualmente há várias evidências de que compostos gerados endogenamente poderiam modificar o DNA gerando adutos. Dentre os compostos endógenos, os produtos carbonílicos α,β-insaturados destacam-se pois reagem como agentes alquilantes bifuncionais com as bases do DNA, formando adutos exocíclicos. O 2,4-decadienal (DDE) é um aldeído α,β-insaturado que além de estar presente em alimentos e poluentes, é um dos mais importantes produtos da lipoperoxidação. Embora há várias indicações sobre a ação genótoxica do DDE, nenhum aduto deste composto com nucleobases havia sido caracterizado. O presente trabalho mostrou que o DDE é um agente alquilante versátil sendo capaz de gerar cinco adutos diferentes. Este estudo também mostrou que o DDE é capaz de gerar os mesmos adutos que outros dois importantes produtos da lipoperoxidação: o 4-0H-nonenal e o 2-octena1. Todos os adutos foram detectados em DNA tratado in vitro com o DDE. Para possibilitar a detecção dos adutos em sistemas mais complexos, foi desenvolvido um método extremamente sensível baseado em HPLC interfaceado com espectrometria de massa em tandem com ionização por electrospray. Foi também desenvolvida uma estratégia de incorporação de um dos adutos (III) em oligonucleotídeos por via química. A estratégia foi utilizada com sucesso na incorporação do aduto em oligonucleotídeos de sequências diversas. Os oligonucleotídeos foram utilizados em ensaios de reparo por excisão de base e replicação in vitro.Structurally diverse carcinogenic compounds bind covalently to DNA producing adducts that can, if not repaired, lead to mutations. Firstly restricted to exogenous compounds, nowadays there are evidences that compounds endogenously generated can modify DNA forming adducts. Among these endogenous compounds, α,β-unsaturated carbonyl products are of special interest due their reactivity as bifunctional alkylating agents towards DNA bases leading to exocyclic adducts. 2,4-decadienal (DDE) is an α,β-unsaturatedaldehyde that in addition to be present in food and pollutants, it is one of the most important lipid peroxidation products. Despite of many indications about the DDE genotoxic properties, there was no information about adducts produced between this compounds and nucleobases. This work showed DDE as a versatile DNA alkylating agent being able to generate five different adducts. This study also showed that DDE can generate the same adducts produced from two other important lipid peroxidation products: 4-0H-nonenal and 2-octena1. All adducts were detected in DNA treated in vitro with DDE. To allow adduct detection in more complex systems, we developed a highly sensitive method based on HPLC coupled to electrospray/tandem mass spectrometry. A strategy to incorporate one adduct (III) into oligonucleotides was also developed. The strategy was successfully applied in the adduct incorporation into diverse sequences of oligonucleotides. They were utilized in base excision repair and in vitro replication experiments
DNA adducts from lipoperoxidation products: characterization, detection, incorporation into oligonucleotides and biological implications
Compostos carcinogênicos estruturalmente diversos ligam-se covalentemente ao DNA formando adutos que, se não reparados, provocam mutações. Inicialmente relacionados apenas a compostos exógenos, atualmente há várias evidências de que compostos gerados endogenamente poderiam modificar o DNA gerando adutos. Dentre os compostos endógenos, os produtos carbonílicos α,β-insaturados destacam-se pois reagem como agentes alquilantes bifuncionais com as bases do DNA, formando adutos exocíclicos. O 2,4-decadienal (DDE) é um aldeído α,β-insaturado que além de estar presente em alimentos e poluentes, é um dos mais importantes produtos da lipoperoxidação. Embora há várias indicações sobre a ação genótoxica do DDE, nenhum aduto deste composto com nucleobases havia sido caracterizado. O presente trabalho mostrou que o DDE é um agente alquilante versátil sendo capaz de gerar cinco adutos diferentes. Este estudo também mostrou que o DDE é capaz de gerar os mesmos adutos que outros dois importantes produtos da lipoperoxidação: o 4-0H-nonenal e o 2-octena1. Todos os adutos foram detectados em DNA tratado in vitro com o DDE. Para possibilitar a detecção dos adutos em sistemas mais complexos, foi desenvolvido um método extremamente sensível baseado em HPLC interfaceado com espectrometria de massa em tandem com ionização por electrospray. Foi também desenvolvida uma estratégia de incorporação de um dos adutos (III) em oligonucleotídeos por via química. A estratégia foi utilizada com sucesso na incorporação do aduto em oligonucleotídeos de sequências diversas. Os oligonucleotídeos foram utilizados em ensaios de reparo por excisão de base e replicação in vitro.Structurally diverse carcinogenic compounds bind covalently to DNA producing adducts that can, if not repaired, lead to mutations. Firstly restricted to exogenous compounds, nowadays there are evidences that compounds endogenously generated can modify DNA forming adducts. Among these endogenous compounds, α,β-unsaturated carbonyl products are of special interest due their reactivity as bifunctional alkylating agents towards DNA bases leading to exocyclic adducts. 2,4-decadienal (DDE) is an α,β-unsaturatedaldehyde that in addition to be present in food and pollutants, it is one of the most important lipid peroxidation products. Despite of many indications about the DDE genotoxic properties, there was no information about adducts produced between this compounds and nucleobases. This work showed DDE as a versatile DNA alkylating agent being able to generate five different adducts. This study also showed that DDE can generate the same adducts produced from two other important lipid peroxidation products: 4-0H-nonenal and 2-octena1. All adducts were detected in DNA treated in vitro with DDE. To allow adduct detection in more complex systems, we developed a highly sensitive method based on HPLC coupled to electrospray/tandem mass spectrometry. A strategy to incorporate one adduct (III) into oligonucleotides was also developed. The strategy was successfully applied in the adduct incorporation into diverse sequences of oligonucleotides. They were utilized in base excision repair and in vitro replication experiments